Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

1.

Double-blind randomised trial of a very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer.

Levine M, Hirsh J, Gent M, Arnold A, Warr D, Falanga A, Samosh M, Bramwell V, Pritchard KI, Stewart D, et al.

Lancet. 1994 Apr 9;343(8902):886-9.

PMID:
7908358
[PubMed - indexed for MEDLINE]
2.

The effect of very-low-dose warfarin on markers of hypercoagulation in metastatic breast cancer: results from a randomized trial.

Falanga A, Levine MN, Consonni R, Gritti G, Delaini F, Oldani E, Julian JA, Barbui T.

Thromb Haemost. 1998 Jan;79(1):23-7.

PMID:
9459316
[PubMed - indexed for MEDLINE]
3.

A feasibility study of continuing dose-reduced warfarin for invasive procedures in patients with high thromboembolic risk.

Larson BJ, Zumberg MS, Kitchens CS.

Chest. 2005 Mar;127(3):922-7.

PMID:
15764777
[PubMed - indexed for MEDLINE]
4.

A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.

Horbach T, Wolf H, Michaelis HC, Wagner W, Hoffmann A, Schmidt A, Beck H.

Thromb Haemost. 1996 Feb;75(2):246-50.

PMID:
8815569
[PubMed - indexed for MEDLINE]
6.

[Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].

Míka P, Behounek J, Skoták M, Nevsímal L.

Acta Chir Orthop Traumatol Cech. 2004;71(4):237-44. Czech.

PMID:
15456102
[PubMed - indexed for MEDLINE]
7.

Prevention of venous thromboembolism after knee arthroplasty. A randomized, double-blind trial comparing enoxaparin with warfarin.

Leclerc JR, Geerts WH, Desjardins L, Laflamme GH, L'Espérance B, Demers C, Kassis J, Cruickshank M, Whitman L, Delorme F.

Ann Intern Med. 1996 Apr 1;124(7):619-26.

PMID:
8607589
[PubMed - indexed for MEDLINE]
8.

Comparison of 10-mg and 5-mg warfarin initiation nomograms together with low-molecular-weight heparin for outpatient treatment of acute venous thromboembolism. A randomized, double-blind, controlled trial.

Kovacs MJ, Rodger M, Anderson DR, Morrow B, Kells G, Kovacs J, Boyle E, Wells PS.

Ann Intern Med. 2003 May 6;138(9):714-9.

PMID:
12729425
[PubMed - indexed for MEDLINE]
10.

Low dose oral anticoagulation therapy in Chinese children with congenital heart disease.

Cheung YF, Leung MP.

J Paediatr Child Health. 1998 Dec;34(6):563-7.

PMID:
9928651
[PubMed - indexed for MEDLINE]
12.

Treating patients with venous thromboembolism: initial strategies and long-term secondary prevention.

Huisman MV, Bounameaux H.

Semin Vasc Med. 2005 Aug;5(3):276-84.

PMID:
16123915
[PubMed - indexed for MEDLINE]
13.
14.

Very low-dose warfarin prophylaxis to prevent thromboembolism in women with metastatic breast cancer receiving chemotherapy: an economic evaluation.

Rajan R, Gafni A, Levine M, Hirsh J, Gent M.

J Clin Oncol. 1995 Jan;13(1):42-6.

PMID:
7799040
[PubMed - indexed for MEDLINE]
Free Article
15.

Ximelagatran versus warfarin for the prevention of venous thromboembolism after total knee arthroplasty. A randomized, double-blind trial.

Francis CW, Davidson BL, Berkowitz SD, Lotke PA, Ginsberg JS, Lieberman JR, Webster AK, Whipple JP, Peters GR, Colwell CW Jr.

Ann Intern Med. 2002 Oct 15;137(8):648-55.

PMID:
12379064
[PubMed - indexed for MEDLINE]
16.

Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors.

Fisher B, Dignam J, Bryant J, DeCillis A, Wickerham DL, Wolmark N, Costantino J, Redmond C, Fisher ER, Bowman DM, Deschênes L, Dimitrov NV, Margolese RG, Robidoux A, Shibata H, Terz J, Paterson AH, Feldman MI, Farrar W, Evans J, Lickley HL.

J Natl Cancer Inst. 1996 Nov 6;88(21):1529-42.

PMID:
8901851
[PubMed - indexed for MEDLINE]
Free Article
17.

Effectiveness of fixed minidose warfarin in the prevention of thromboembolism and vascular death in nonrheumatic atrial fibrillation.

Pengo V, Zasso A, Barbero F, Banzato A, Nante G, Parissenti L, John N, Noventa F, Dalla Volta S.

Am J Cardiol. 1998 Aug 15;82(4):433-7.

PMID:
9723629
[PubMed - indexed for MEDLINE]
18.
19.

Low-dose warfarin in rehabilitating stroke survivors.

Ginsberg JS, Bates SM, Oczkowski W, Booker N, Magier D, MacKinnon B, Weitz J, Kearon C, Cruickshank M, Julian JA, Gent M.

Thromb Res. 2002 Sep 15;107(6):287-90.

PMID:
12565715
[PubMed - indexed for MEDLINE]
20.

Minimum effective intensity of oral anticoagulant therapy in primary prevention of coronary heart disease.

MacCallum PK, Brennan PJ, Meade TW.

Arch Intern Med. 2000 Sep 11;160(16):2462-8.

PMID:
10979057
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk